Securities code: 003020 securities abbreviation: Hefei Lifeon Pharmaceutical Co.Ltd(003020) Announcement No.: 2022-002 Hefei Lifeon Pharmaceutical Co.Ltd(003020)
Announcement of resolutions of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shareholders’ meeting did not veto the proposal.
2. This shareholders’ meeting does not involve changing the resolutions adopted at previous shareholders’ meetings.
1、 Convening and attendance of the meeting
1. Meeting time
(1) On site meeting time: 15:00 p.m. on Thursday, January 13, 2022.
(2) Online voting time: the voting time through the trading system of Shenzhen stock exchange is: 9:15-9:25, 9:30-11:30 and 13:00-15:00 on January 13, 2022; The time of voting through the Internet voting system of Shenzhen stock exchange is 9:15-15:00 on January 13, 2022.
2. Venue of the on-site meeting: conference room of the company, No. 522, Wangjiang West Road, Hefei, Anhui Province.
3. Meeting mode: the combination of on-site voting and online voting.
4. Convener: the board of directors of the company.
5. Moderator: Mr. Ji Junqiu, chairman of the company.
6. The convening, convening and voting procedures of this meeting comply with the company law of the people’s Republic of China and other laws and regulations, normative documents and the articles of association.
7. Attendance at the meeting
(1) Overall attendance
There are 21 shareholders and shareholders’ proxies voting on site and online, representing 62840900 shares, accounting for 67.83% of the total voting shares of the company.
Among them, there are 21 shareholders and shareholder agents who vote on site, representing 62840900 shares, accounting for 67.83% of the total voting shares of the company. There are 0 shareholders voting through the Internet, representing 0 shares, accounting for 0% of the total voting shares of the company.
(2) Attendance of minority shareholders
There are 13 minority shareholders and agents who vote on site and online, representing 10080500 shares, accounting for 10.88% of the total voting shares of the company.
Among them, there are 13 minority shareholders and agents who vote on site, representing 10080500 shares, accounting for 10.88% of the total voting shares of the company.
There are 0 minority shareholders and agents voting online, representing 0 shares, accounting for 0% of the total voting shares of the company.
8. All directors, supervisors and Secretary of the board of directors attended the meeting. Other senior managers attended the meeting as nonvoting delegates. The witness lawyers attended the meeting as nonvoting delegates to witness the meeting.
2、 Deliberation and voting of proposals
The general meeting of shareholders adopted a combination of on-site voting and online voting, and considered and adopted the following proposals:
1. Proposal on using some idle raised funds for cash management
It is agreed that the company will use idle raised funds of no more than RMB 300 million (including RMB 300 million) for cash management without affecting the construction of investment projects with raised funds and the normal operation of the company. The service life shall be valid within 12 months from the date of deliberation and approval by the general meeting of shareholders. The above amount is within the validity period of the resolution, and the funds can be accumulated and used.
Authorize the company’s management to exercise relevant decision-making power within the limit, sign relevant contract documents, and be responsible for handling specific matters of cash management such as the company’s use of idle raised funds to purchase financial products. The specific investment activities shall be organized and implemented by the company’s financial department.
Voting:
Agreed: 62840900 shares, accounting for 100.00% of the total number of valid voting shares attending the meeting;
Objection: 0 shares, accounting for 0.00% of the total number of valid voting shares attending the meeting;
Abstention: 0 shares, accounting for 0.00% of the total number of valid voting shares attending the meeting.
Voting of minority shareholders:
Agreed: 10080500 shares, accounting for 100% of the total shares held by minority shareholders attending the meeting;
Objection: 0 shares, accounting for 0.00% of the total shares held by minority shareholders attending the meeting;
Abstention: 0 shares, accounting for 0.00% of the total shares held by minority shareholders attending the meeting.
Outcome: adopted.
2. Proposal on using idle self owned funds for cash management
It is agreed that the company will use idle self owned funds of no more than 350 million yuan (including 350 million yuan) for cash management for low-risk investment products with high safety and good liquidity. The term of use shall be valid within 12 months from the date of deliberation and approval by the general meeting of shareholders, and shall be used in rolling within the authorized amount.
Authorize the management of the company to exercise the investment decision-making power and sign relevant contracts and documents within the above validity period and capital limit. The specific investment activities shall be organized and implemented by the Finance Department of the company.
Voting:
Agreed: 62840900 shares, accounting for 100.00% of the total number of valid voting shares attending the meeting;
Objection: 0 shares, accounting for 0.00% of the total number of valid voting shares attending the meeting;
Abstention: 0 shares, accounting for 0.00% of the total number of valid voting shares attending the meeting.
Voting of minority shareholders:
Agreed: 10080500 shares, accounting for 100% of the total shares held by minority shareholders attending the meeting;
Objection: 0 shares, accounting for 0.00% of the total shares held by minority shareholders attending the meeting;
Abstention: 0 shares, accounting for 0.00% of the total shares held by minority shareholders attending the meeting.
Outcome: adopted.
3、 Legal opinions issued by lawyers
Li Meng and Wang Wenhao, the witness lawyers appointed by Beijing Jingtian Gongcheng law firm, attended the shareholders’ meeting, witnessed it and issued legal opinions. They believed that the convening and convening procedures of the company’s shareholders’ meeting were in line with Chinese laws and regulations and the articles of Association; The qualification of the personnel attending the general meeting of shareholders is legal and valid; The qualification of the convener of the general meeting of shareholders meets the provisions of Chinese laws and regulations and the articles of Association; The voting procedures and results of this general meeting of shareholders are legal and valid.
4、 Documents for future reference
1. Resolution of Hefei Lifeon Pharmaceutical Co.Ltd(003020) the first extraordinary general meeting of shareholders in 2022;
2. Legal opinion on Hefei Lifeon Pharmaceutical Co.Ltd(003020) the first extraordinary general meeting of shareholders in 2022.
Hefei Lifeon Pharmaceutical Co.Ltd(003020)
Board of directors
January 14, 2022
